# To Study the Safety and Efficacy of Midodrine With Albumin Versus Albumin Alone in Hepatic Hydrothorax

> **NCT03645642** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 8 (actual)

## Conditions studied

- Hepatic Hydrothorax

## Interventions

- **DRUG:** Midodrine
- **BIOLOGICAL:** Albumin
- **DRUG:** Diuretics

## Key facts

- **NCT ID:** NCT03645642
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-30
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03645642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03645642, "To Study the Safety and Efficacy of Midodrine With Albumin Versus Albumin Alone in Hepatic Hydrothorax". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03645642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*